Clinical Trials Directory

Trials / Unknown

UnknownNCT06049550

The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathological markers have been proved to have clinical and prognostic value in both non diabetic and diabetic kidney diseases. To discriminate lesions by various degrees of severity, the Working Group of the Renal Pathology Society (RPS) developed a pathologic classification for DKD in 2010. The classification is based on glomerular lesions, with a separate evaluation for interstitial and vascular lesions. In a decade, there were several new characteristics common to DKD, such as the presence of mesangiolysis, glomerular hyalinosis, segmental sclerosis and extracapillary hypercellularity, which have been noted in patients with diabetes and may have prognostic importance. But it is still unclear whether thickening of Bowman's capsule predicts the progression of DKD.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2023-10-01
Primary completion
2023-10-01
Completion
2023-10-31
First posted
2023-09-22
Last updated
2023-09-22

Source: ClinicalTrials.gov record NCT06049550. Inclusion in this directory is not an endorsement.